BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND ESR1, ESR, 2099, ENSG00000091831, RP1-130E4_1, NR3A1, ESRA, DKFZp686N23123, ER, Era AND Treatment
30613 results:

  • 1. Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair.
    Ida N; Okura M; Tanaka S; Hosono N; Yamauchi T
    Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38785163
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cutaneous Lagenidium deciduum infection in a patient with relapsed acute myeloid leukemia.
    Theophilopoulos J; King R; Citta A; Alford C; Dotson N; Cañete-Gibas C; Sanders C; Wiederhold N; Ligon JA; Trieu C
    BMC Infect Dis; 2024 May; 24(1):515. PubMed ID: 38778275
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Low subcutaneous adipose tissue and myosteatosis are prognostic factors after allogeneic hematopoietic stem cell transplantation.
    Barajas Ordonez F; Zeller Y; Wolleschak D; Hinnerichs M; Rodríguez-Feria P; Mougiakakos D; Aghayev A; Kardas H; Mikusko M; Borggrefe J; Surov A
    Clin Nutr ESPEN; 2024 Jun; 61():274-280. PubMed ID: 38777443
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A retrospective study of an irradiation-based conditioning regimen and chidamide maintenance therapy in T-ALL/LBL.
    Wang X; Deng Y; He G; Lai S; Li Y; Zhang S; He Y; Han Y; Zhang L; Su Y; Liu F; Yi H
    Hematology; 2024 Dec; 29(1):2356300. PubMed ID: 38776229
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid leukemia.
    Vandewalle N; Satilmis H; Verheye E; Fan R; Wang Y; De Groof TWM; Bridoux J; Kerre T; De Beule N; De Becker A; De Bruyne E; Menu E; Vanderkerken K; Breckpot K; Devoogdt N; De Veirman K
    Theranostics; 2024; 14(7):2656-2674. PubMed ID: 38773967
    [No Abstract]    [Full Text] [Related]  

  • 6. Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells.
    Qiu F; Jiang P; Zhang G; An J; Ruan K; Lyu X; Zhou J; Sheng W
    Nat Commun; 2024 May; 15(1):4327. PubMed ID: 38773088
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of aging on acute myeloid leukemia epidemiology and survival outcomes: A real-world, population-based longitudinal cohort study.
    Han HJ; Choi K; Suh HS
    PLoS One; 2024; 19(5):e0300637. PubMed ID: 38771863
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Strategies for increasing accrual in cancer clinical trials: What is the evidence?
    Michaels M; Weiss ES; Sae-Hau M; Illei D; Lilly B; Szumita L; Connell B; Lee M; Cooks E; McPheeters M
    Cancer Med; 2024 May; 13(10):e7298. PubMed ID: 38770644
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. treatment intensity affects immune reconstitution even after childhood cancer not treated with hematopoietic stem cell transplantation.
    Antikainen E; Grönroos M; Huurre A; Korhonen L; Peltola V; Lähteenmäki P; Schuez-Havupalo L
    Cancer Rep (Hoboken); 2024 May; 7(5):e2069. PubMed ID: 38767518
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Concomitantly Diagnosed Disseminated
    Stanton DJ; Quadri NZ; Tanabe MB
    J Investig Med High Impact Case Rep; 2024; 12():23247096241253343. PubMed ID: 38767131
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Application and prognostic relevance of CD34 detection in immunophenotyping of pediatric acute B lymphoblastic leukemia.
    Zha W; Yuan Y; Yang T; Zhu LJ; Kong WY; Zhuo JJ
    Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3384-3390. PubMed ID: 38766795
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cytoreductive chemotherapy in induction therapy plays a key role in the prognosis of patients with low-risk acute promyelocytic leukaemia.
    Zhu X; Tang F; Yu W; Zhao X; Qin Y; Jiang Q; Huang X; Jiang H
    J Cell Mol Med; 2024 May; 28(10):e18252. PubMed ID: 38766688
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.
    Ranniger RL; Lamaita RM; D'Abreu BF; Tolentino MR; Cândido EB; Andrade WP; Nogueira-Rodrigues A; Silva-Filho AL
    Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765513
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. PD-1 blockade immunotherapy as a successful rescue treatment for disseminated adenovirus infection after allogeneic hematopoietic stem cell transplantation.
    Zhou F; Du F; Wang Z; Xue M; Wu D; Chen S; He X
    J Hematol Oncol; 2024 May; 17(1):34. PubMed ID: 38764055
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. TCL1A-expressing B cells are critical for tertiary lymphoid structure formation and the prognosis of oral squamous cell carcinoma.
    Xie W; Lu J; Chen Y; Wang X; Lu H; Li Q; Jin N; He J; Ou L; Ni J; Shen Y; Shao L
    J Transl Med; 2024 May; 22(1):477. PubMed ID: 38764038
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Impact of Fee For Service on the Efficiency and Survival of Seguro Popular's Patients With Acute Lymphoblastic leukemia in Mexico.
    Cerecero-García D; Macías-González F; Muñoz-Aguirre P; Huerta-Gutierrez R; Zapata M; Rivera-Luna R; Lajous M; Bautista-Arredondo S
    JCO Glob Oncol; 2024 May; 10():e2300060. PubMed ID: 38754053
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Pharmacogenomics, Race, and treatment Outcome in Pediatric Acute Myeloid leukemia.
    Lamba JK; Marrero R; Wu H; Cao X; Parcha PK; Karol SE; Inaba H; Kuo DJ; Degar BA; Heym K; Taub JW; Lacayo NJ; Pui CH; Ribeiro RC; Pounds SB; Rubnitz JE
    JAMA Netw Open; 2024 May; 7(5):e2411726. PubMed ID: 38753328
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Discovery of indole-2-one derivatives as BRD4 (BD1) selective inhibitors.
    Qiao XP; Wang XT; Wang S; Mu HX; Wang QS; Chen SW
    Bioorg Med Chem; 2024 May; 106():117752. PubMed ID: 38749341
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
    Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
    Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Therapeutic Choices in Patients with Ph-Positive Chronic Myelogenous leukemia In Mexico in the era of Tyrosine Kinase Inhibitors: Stem Cell Transplantation or Tyrosine Kinase Inhibitors? Fifteen Years Later.
    Max RN; Daniela SB; Moisés M GP; Edgar J HF; Merittzel A MR; María de L PM; Juan C OG; Guillermo J RD; Guillermo J RA
    Rev Invest Clin; 2024; 76(2):91-96. PubMed ID: 38740380
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1531.